Making Good Health Affordable

Drug pricing has long been a topic of fierce discussions across United States. The disapproval of a common American around baseline drug prices has been quite apparent over the years. This significance of the issue isn’t lost on Biden administration. The government has been exploring different solutions to establish a sense of control over the price-point of different drugs, and finally concrete steps are being taken. As per the official statement issued by the U.S. government, there will be an opening in the upcoming budget for negotiations over drug prices. The White House revealed in its statement that “President Biden supports reforms that would bring down drug prices by letting Medicare negotiate payment for certain high-cost drugs.”

If certain reports are to be believed, the government will also look to introduce legislation that will instantly make drug manufacturers liable to pay rebates in case the prices outpace the inflation.

The proposed reforms will also cut back federal expenses sizably, saving up almost half a trillion over the next 10 years. This saved amount can fund a variety of projects undertaken by the government to make advancements across different sectors. While Biden has emphasized on this issue during his campaign as well, turning it into a reality still remains a challenge due to limited Democratic majority in the Senate.

Nevertheless, drug prices aren’t the only channel through which U.S. government is looking to improve the healthcare sector. A proposal is prepared to allot $6.5 billion for the creation of a new National Institute of Health arm. It will be named Advanced Research Projects Agency for Health (ARPA-H). This institution is said to be inspired by the widely-respected DARPA institution (Defense Advanced Research Projects Agency), which played a pivotal role in the creation of ground-breaking things like Internet, GPS, and a lot more that the world thought was impossible before it was created. The intention is to emulate the achievements of DARPA in more of a scientific capacity this time and make serious progression towards finding concrete answers for diseases like cancer, diabetes, Alzheimer’s etc.

Share

Related

What does “Patient-Centricity” mean to clinical trial enrollment?

Patient recruitment remains the leading cause of delay for...

Chief Procurement Officer Summit April 2025

The Chief Procurement Officer Summit is an invitation-only event...

Transforming Pharma with Key Trends and Technologies at AUTOMA+ 2024

AUTOMA+ 2024 passed in Zurich, Switzerland on 18-19 November...

An Unfamiliar Venture

An enlightened millennial doesn’t need to be told about...

The Entry of Big Data intothe Insurance Space

Big Data—a term that emerged to describe datasets whose...

A Nationwide Push to Satisfy Your Cravings

One of the best things about human beings is...

The Changing Clinical Trial Space

The role of technology in drug development and the...

Introducing The Customer Connect Expo: A New Era of Engagement

In the ever-evolving world of business, staying connected with...

A Game-Changer for Cryptocurrency

Human imagination knows no bounds and that is reflected...

Creating a ‘Connected’ Retail Experience

The human arsenal is constructed using some of the...

Latest

No posts to display

No posts to display